21 CFR 522.2474

§ 522.2474 Tolazoline.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 522.2474, § 522.2474 Tolazoline, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87552
Permanent ID: ys:prov:87552@1
SHA-256: ca17a4fb55a00d9f335d9fec7f71ba6e24d154ba2a09244481b4557870c6cc20

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of solution contains tolazoline hydrochloride equivalent to 100 milligrams (mg) of base activity. (b) Sponsor. See No. 059399 in § 510.600(c) of this chapter. (c) Conditions of use in horses—(1) Amount. Administer slowly by intravenous injection 4 mg per kilogram of body weight or 1.8 mg per pound (4 milliliters (mL) per 100 kilograms or 4 mL per 220 pounds). (2) Indications for use. For use in horses when it is desirable to reverse the effects of sedation and analgesia caused by xylazine. (3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.